F&G Q1 2026 slides: strong sales growth offset by investment headwinds

F&G Annuities reported Q1 2026 adjusted net earnings of $110 million, or $0.82 per share, but EPS of $0.93 missed the $1.39 consensus by 33% due to a $44 million shortfall in alternative investment income. Offsetting the miss, gross sales rose 10% to $3.2 billion, AUM before reinsurance increased 11% to $74.5 billion, and the company returned $67 million to shareholders via dividends and buybacks. Shares fell 7.95% after hours, then rebounded 4.51% premarket, leaving the update mixed but with a negative earnings tone.

Analysis

The market is punishing the wrong variable. The earnings miss is being read as a balance-sheet quality problem, but the more important signal is that F&G’s earnings power is becoming more sensitive to mark-to-model alternative realizations than to core spread and fee growth. That usually creates a timing mismatch: the stock de-rates on a single quarter even though the embedded value engine can still compound if sales, reinsurance, and capital returns continue to scale.

Second-order, the real beneficiary is not just Blackstone but the broader private-credit ecosystem. F&G’s portfolio mix and reinsurance structure imply continued demand for structured credit, private origination, and asset-intensive solutions, which should support BX economics even if reported insurer earnings stay choppy. For FNF, the more relevant issue is capital allocation optionality: a discounted subsidiary with buybacks can be a quiet source of NAV accretion, but only if the market stops treating alternative income volatility as a proxy for underwriting risk.

The contrarian setup is that consensus is likely extrapolating one quarter of alternative under-earning into a permanent ROE problem, when the bigger risk is actually the opposite: if private assets start marking more favorably, earnings can snap back quickly and the stock is too cheap for that convexity. The key catalyst window is the next 1-2 quarters, when management can either validate the cadence of alternative realizations or force another reset in expected returns. If the guide remains stable and repurchases continue near current prices, the discount-to-book likely narrows before fundamental consensus catches up.

Risk is not solvency; it is narrative fragility. Life/annuity names are vulnerable to headline-driven multiple compression whenever liquidity, private credit, or unrealized gains become investor focus, so even a solid operating quarter can trade poorly until the market sees a cleaner bridge from portfolio income to cash earnings. That makes the stock more suitable for tactical positioning than a blind long, but the asymmetry improves materially if the shares stay below tangible book while buybacks remain active.

Key Decisions for Investors

• Long FGN into the next earnings print or investor update, sized as a tactical value trade: upside is re-rating toward book discount normalization if alternative income stabilizes; downside is limited by buybacks and a still-strong capital position.
• Pair trade: long FGN / short a more expensive life-and-annuity peer with higher exposure to capital-market narrative risk, to isolate the valuation gap driven by alternative-income volatility rather than sector beta.
• Add BX on any weakness tied to insurer/private-credit headline risk over the next 1-3 months; F&G’s asset mix is supportive for private origination demand, and the market is likely over-discounting that channel.
• Accumulate FNF on dips as a sum-of-parts capital allocation play over 3-6 months: the subsidiary discount plus buybacks create incremental NAV uplift if management keeps repurchasing below book.
• Avoid aggressive shorting of FGN after this selloff; the cleaner trade is to wait for a 1-2 quarter earnings reset. If alternative income normalizes, the stock can re-rate quickly, making the short carry unattractive.